Inventor
KOLESNIKOV ALEKSANDR
US37 patents
⚠️ This page may combine multiple inventors who share the name “KOLESNIKOV ALEKSANDR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
25 patentsUS8785626B2Jul 22, 2014
Benzoxazepin PI3K inhibitor compounds and methods of use
GENENTECH INC54 citations98
US8343955B2Jan 1, 2013
Benzoxazepin PI3K inhibitor compounds and methods of use
GENENTECH INC39 citations98
US8586574B2Nov 19, 2013
Benzoxazepin PI3K inhibitor compounds and methods of use
GENENTECH INC19 citations92
US7928248B2Apr 19, 2011
Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC10 citations83
US10842799B2Nov 24, 2020
Serine/threonine kinase inhibitors
GENENTECH INC1 citations73
US10517878B2Dec 31, 2019
Serine/threonine kinase inhibitors
GENENTECH INC2 citations73
US10278975B2May 7, 2019
Serine/threonine kinase inhibitors
GENENTECH INC1 citations73
US9867833B2Jan 16, 2018
Serine/threonine kinase inhibitors
GENENTECH INC3 citations73
US9546178B2Jan 17, 2017
Benzoxazepin PI3K inhibitor compounds and methods of use
GENENTECH INC3 citations73
US9434725B2Sep 6, 2016
5-azaindazole compounds and methods of use
GENENTECH INC4 citations72
US9670228B2Jun 6, 2017
Benzoxazepin PI3K inhibitor compounds and methods of use
GENENTECH INC1 citations63
US11376260B2Jul 5, 2022
Serine/threonine kinase inhibitors
GENENTECH INC0 citations62
US8952043B2Feb 10, 2015
Benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC3 citations62
US8846762B2Sep 30, 2014
Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC3 citations62
US11236046B2Feb 1, 2022
Substituted heterocyclic sulfonamide compounds useful as TRPA1 modulators
GENENTECH INC0 citations61
US12139496B2Nov 12, 2024
Therapeutic compounds and methods of use thereof
GENENTECH INC0 citations60
US10947251B2Mar 16, 2021
Therapeutic compounds and methods of use thereof
GENENTECH INC1 citations60
US9198918B2Dec 1, 2015
Benzoxazepin PI3K inhibitor compounds and methods of use
GENENTECH INC0 citations52
US9175009B2Nov 3, 2015
Benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC0 citations52
US9850239B2Dec 26, 2017
Pyrazolo[3,4-c]pyridine compounds and methods of use
GENENTECH INC1 citations51
US9309265B2Apr 12, 2016
Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
GENENTECH INC0 citations51
US10988478B1Apr 27, 2021
Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
GENENTECH INC0 citations49
US11434250B2Sep 6, 2022
Pyrazolo[1,5a]pyrimidine derivatives as IRAK4 modulators
GENENTECH INC0 citations48
US10654824B2May 19, 2020
2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
GENENTECH INC0 citations41
US10550117B2Feb 4, 2020
2-azabicyclo[3.1.0]hexan-3-one derivatives and methods of use
GENENTECH INC0 citations41
BLAQUIERE NICOLE
3 patentsUS8673952B2Mar 18, 2014
Benzoxepin PI3K inhibitor compounds and methods of use
BLAQUIERE NICOLE42 citations97
US8242104B2Aug 14, 2012
Benzoxazepin P13K inhibitor compounds and methods of use
BLAQUIERE NICOLE53 citations97
US8263633B2Sep 11, 2012
Benzoxepin PI3K inhibitor compounds and methods of use
BLAQUIERE NICOLE29 citations92
JENKINS THOMAS E
2 patentsDO STEVEN
2 patentsKOLESNIKOV ALEKSANDR
2 patentsUS8299110B2Oct 30, 2012
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors
KOLESNIKOV ALEKSANDR8 citations81
US8778625B2Jul 15, 2014
2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
KOLESNIKOV ALEKSANDR3 citations60